<DOC>
	<DOCNO>NCT00216333</DOCNO>
	<brief_summary>The use fixed-dose combine ( FDC ) drug treatment tuberculosis National Tuberculosis Programmes recommend International Union Against Tuberculosis Lung Disease ( The Union ) World Health Organisation . The advantage FDC drug include prevent emergence drug resistance due monotherapy , reduce risk incorrect dosage , simplify procurement prescribing practice , aid adherence facilitate directly observe treatment . Recent bioavailability study four-drug FDC tablet demonstrate satisfactory result . In study , test efficacy compound , give initial intensive phase treatment patient newly diagnose smear positive pulmonary tuberculosis . This follow four month treatment two-drug FDC rifampicin isoniazid .</brief_summary>
	<brief_title>Multicenter Trial Evaluation Fixed Dose Combined Tablet Treatment Pulmonary Tuberculosis</brief_title>
	<detailed_description>This multiple country , multicenter study , use parallel group open-label randomised trial design . The primary objective investigation ass efficacy , acceptability toxicity combine FDC regimen chemotherapy patient newly diagnose smear positive pulmonary tuberculosis comparison standard regimen use separate drug . Patients allocate random either : - initial intensive phase eight week daily ethambutol , isoniazid , rifampicin pyrazinamide , fix dose COMBINED tablet , follow 18 week rifampicin isoniazid , fix dose combine tablet three time week ( 2COMB/4 ( RH ) 3 ) - drug give SEPARATE formulation initial intensive phase eight week , follow 18 week rifampicin isoniazid , fix dose combine tablet , three time week ( 2SEPA/4 ( RH ) 3 )</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<criteria>Patients newly diagnose pulmonary tuberculosis two sputum specimen positive acidfast bacillus direct smear microscopy previous antituberculosis chemotherapy age 18 year firm home address readily accessible visit duration trial ( include follow period ) agree participate study give sample blood HIV test patient moribund state , TB meningitis , preexist disease : insulindependent diabetes , liver kidney disease , blood disorder , peripheral neuritis , pregnancy breast feeding , psychiatric illness alcoholism contraindication medication study regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>tuberculosis</keyword>
	<keyword>fix dose combination</keyword>
	<keyword>DOT</keyword>
	<keyword>shot-course chemotherapy</keyword>
</DOC>